Biology of Cerebral Arteriovenous Malformations and Prognosis of Cerebral Arteriovenous Malformations — BioMAV  

Cerebral Arteriovenous Malformations Clinical Trial

Official title: Biology of Cerebral Arteriovenous Malformations : Study of the Link Between Blood Biomarkers and the Haemorrhagic Prognosis of Cerebral Arteriovenous Malformations

Status Recruiting

Clinical Trial Summary

The cerebral arteriovenous malformations correspond to the formation of an entanglement of morphologically abnormal vessels called nidus, which shunt the blood circulation directly from the arterial circulation to the venous circulation.

The cerebral arteriovenous malformations are an important cause of hemorrhagic stroke.

The hypothesis is that cerebral haemorrhage associated with a cerebral arteriovenous malformations would come from peri-nidal micro-vessels, in connection with infiltration of leucocytes and / or defective maintenance of microvascular integrity by platelets.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Arteriovenous Malformations
• Cerebral Arteriovenous Malformations
• Congenital Abnormalities
• Hemangioma
• Intracranial Arteriovenous Malformations
• Ruptured or Unruptured Cerebral Arteriovenous Malformations

• NCT number: NCT03676868
• Study type: Observational
• Source: Fondation Ophtalmologique Adolphe de Rothschild
• Contact: Amélie Yavchitz
• Phone: 01 48 63 64 54
• Email: ayavchitz@for.paris
• Status: Recruiting
• Start date: November 20, 2018
• Completion date: November 19, 2028